Literature DB >> 16234580

The many sounds of T lymphocyte silence.

Ignacio Melero1, Ainhoa Arina, Lieping Chen.   

Abstract

It is not unusual for antigens and potentially responsive T cells to co-exist in the same organism while these T cells remain silent and do not mount life-threatening immune responses. A rich array of mechanisms has been proposed to explain these observations. T cell silencing is controlled in multiple levels. Initially, dendritic cells and regulatory T cells appear to play critical roles. In addition, T cell immunity is tightly regulated by a molecular network of cytokines and cell receptor interactions by the opposed surfaces of antigen-presenting cells and T cells. Recognition of a specific antigen is therefore shaped and tuned by co-stimulatory and co-inhibitory receptor-ligand pairs. At last, immunologists are beginning to exploit the rules governing these assorted sounds of T cell silence.

Mesh:

Year:  2005        PMID: 16234580     DOI: 10.1385/IR:33:2:135

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  118 in total

1.  Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells.

Authors:  M L Albert; M Jegathesan; R B Darnell
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

Review 2.  The role of dendritic cell subsets in immunity to viruses.

Authors:  Francis R Carbone; William R Heath
Journal:  Curr Opin Immunol       Date:  2003-08       Impact factor: 7.486

Review 3.  An innate sense of danger.

Authors:  P Matzinger
Journal:  Semin Immunol       Date:  1998-10       Impact factor: 11.130

4.  Costimulation: building an immunological synapse.

Authors:  M L Dustin; A S Shaw
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

5.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.

Authors:  John R Sedy; Maya Gavrieli; Karen G Potter; Michelle A Hurchla; R Coleman Lindsley; Kai Hildner; Stefanie Scheu; Klaus Pfeffer; Carl F Ware; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2004-11-28       Impact factor: 25.606

6.  4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.

Authors:  Wojciech Dawicki; Edward M Bertram; Arlene H Sharpe; Tania H Watts
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

7.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

8.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

9.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Authors:  Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

Review 10.  IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Authors:  Andrew L Mellor; David H Munn
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

View more
  3 in total

1.  Genomic expression analysis by single-cell mRNA differential display of quiescent CD8 T cells from tumour-infiltrating lymphocytes obtained from in vivo liver tumours.

Authors:  Wei Zhang; Jianqing Ding; Yan Qu; Hongliang Hu; Meihua Lin; Amit Datta; Alan Larson; George E Liu; Biaoru Li
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

2.  Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development.

Authors:  Martina Gatzka; Ryan H Newton; Craig M Walsh
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

3.  A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases.

Authors:  Ricardo Palacios; Joaquin Goni; Ivan Martinez-Forero; Jaime Iranzo; Jorge Sepulcre; Ignacio Melero; Pablo Villoslada
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.